Key takeaways:

Patients were treated with anthracycline and/or taxane.

Gray matter and surface area decreased in the isthmus cingulate and pars opercularis.

These findings should not dissuade patients from getting needed care.

Women who were treated with anthracycline-taxane chemotherapy for breast cancer lost gray matter in their frontal, parietal and temporal regions, according to a poster presented at the Alzheimer’s Association International Conference.

Approximately one-third of breast cancer survivors experience cognitive impairment induced by chemotherapy, also known as chemobrain , within 12 months of treatment initiation, the researchers wrote.

Approximately a third of breast cancer survivors experience “chemobrain” within 12 months of starting treatment. Image: Adobe Sto

See Full Page